Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunelm Regulatory News (DNLM)

Share Price Information for Dunelm (DNLM)

Share Price is delayed by 15 minutes
Get Live Data
777.00    10.00 (1.30%)
Bid:
779.00
Ask:
780.00
Spread: 1.00 (0.128%)
Market Cap: £1.57b
DNLM Live PriceLast checked at - London Stock Exchange

Intraday Dunelm Share Chart

Targets for long term share incentive awards

10 May 2021 07:00

RNS Number : 9797X
Dunelm Group plc
10 May 2021
Β 

DUNELM GROUP plc

(the "Company")

Β 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL

RESPONSIBILITY AND CONNECTED PERSONS

10 May 2021

Β 

Targets for long term share incentive awards granted to Nick Wilkinson and Laura Carr in 2020

Β 

As previously announced, on 20 November 2020, theΒ Company granted a conditional nil-cost option under the Long-term Incentive Plan (theΒ FY21 -23 Award) to Nick Wilkinson and Laura Carr as set out in the table below.

Β Β Name

Role

Number of conditional nil cost options awarded under Long-Term Incentive Plan

Nick Wilkinson

CEO

94,846

Laura Carr

CFO

58,166

Β 

The above options may be exercised on or after 20 November 2023, subject to the satisfaction of performance conditions over the three financial years commencing on 28 June 2020.

Β 

As disclosed in the FY20 Directors' Remuneration Report, the Committee felt it was unlikely that it would be able to set meaningful but stretching three-year targets for the FY21-23 Award at the grant date, given the significant Covid related uncertainty in the wider economic environment. In a departure from its normal practice, and in line with the Investment Association's guidance issued in May 2020, the Committee agreed to set the performance conditions applicable to the award by May 2021.

The Committee has taken into account the Group's business plan, as well as the outlook for the sector and general macroeconomic conditions, and the range of analysts' consensus forecasts for FY23. Following careful consideration, the Committee has set the performance condition as set out below, with the number stated being the figure for fully diluted earnings per share (EPS) as set out in the financial statements of the Company for the year ending June 2023:

FY21-23Β LTIPΒ AwardΒ -Β PerformanceΒ targets

Β 

Fully diluted EPS of the Company for FY23

Less than 60.0p

60.0p

65.0p

72.5p

80.0p or more

Compound annual growth rate

Β 

11.8%

14.8%

19.1%

23.0%

Percentage of the FY21-23 Award vesting*

Nil

10%

50%

75%

100%

Β 

*Performance between each of these percentage thresholds will be calculated on a straight line basis

Β 

The proposed performance targets represent significant growth in total profitability compared to the pre-Covid-19 FY19 financial performance.Β The Remuneration Committee reserves the right to adjust the targets in the event of unexpected changes in tax rates.

In line with its 2020 Remuneration Policy, the Remuneration Committee can apply malus or clawback to the award, and has discretion to vary formulaic outturns where this does not reflect underlying performance or is inappropriate in the context of unexpected or unforeseen circumstances.

Β 

Further, in accordance with the shareholding requirements set out in the 2020 Remuneration Policy, on exercise Mr Wilkinson and Mrs Carr have each committed to retain all of the shares vesting (after sale to cover their tax and national insurance liability on exercise), until 20 November 2025, and at least two thirds of these for the duration of employment. In addition, shareholding requirements apply for the duration of employment and for two years from termination of employment, as set out in the 2020 Remuneration Policy.

Β 

Name of authorised Company official responsible for making this notification:

Β 

Dawn Durrant, Company Secretary

For further information please contact:

Dunelm Group plc

Investorrelations@dunelm.com

Dawn Durrant, Company Secretary

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHARMATMTMMBLB
Date   Source Headline
1st Jun 20267:00 amRNSTotal Voting Rights
12th May 20267:00 amRNSDirector/PDMR Shareholding
8th May 20263:27 pmRNSDirector/PDMR Shareholding - Replacement
8th May 202611:00 amRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTotal Voting Rights
16th Apr 20267:00 amRNSThird quarter trading update
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSDirector/PDMR Shareholding
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20263:24 pmRNSHolding(s) in Company
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSPurchases of Shares During Open Periods
13th Feb 202611:00 amRNSDirector/PDMR Shareholding
10th Feb 20267:00 amRNSInterim Results
2nd Feb 20267:00 amRNSTotal Voting Rights
15th Jan 20267:00 amRNSSecond quarter and first half trading update
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
9th Dec 20257:00 amRNSDirector/PDMR Shareholding
3rd Dec 20257:00 amRNSPDMR Shareholding
28th Nov 20257:00 amRNSTotal Voting Rights
25th Nov 202510:14 amRNSDirector/PDMR Shareholding Amendment
25th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20252:30 pmRNSResult of AGM
11th Nov 20257:00 amRNSDirector/PDMR Shareholding
4th Nov 20257:00 amRNSDirector/PDMR Shareholding
31st Oct 20259:52 amRNSDirector/PDMR Shareholding
31st Oct 20257:00 amRNSTotal Voting Rights
28th Oct 20257:00 amRNSDirector/PDMR Shareholding
23rd Oct 20257:00 amRNSFirst quarter trading statement
9th Oct 202510:00 amRNSNotice of AGM, Annual Report and Accounts
8th Oct 20257:00 amRNSBlock Listing Six Monthly Return
2nd Oct 20257:00 amRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.